The Awakening of Hibernating Myocardium: Shockwave Therapy
The CAST-HF clinical trial results on shockwave therapy for the recovery of hibernating myocardium concurrently with revascularization surgery.
HeartMate 3 in Patients with Extracorporeal Life Support: Improved Outcomes over Previous Devices and Comparable to Transplantation?
Three-Year Results of the ECSL Registry in Extracorporeal Life Support Patients Receiving HM3 Implants from January 2016 to April 2022 Across 14 Centers, Compared to Other Long-Term Devices.
Is Right Axillary Artery Cannulation Safe in Dissected Right Axillary Arteries in Acute Type A Aortic Dissections?
Observational, single-center, retrospective study analyzing the safety, in terms of hospital mortality and stroke, of cannulation over a dissected right axillary artery.
The Ebstein anomaly and the difficulty in drawing conclusions for decision-making
Results from the experience of six centers in Australia and New Zealand in the management of Ebstein anomaly over 34 years.
On-X® Aortic Prosthesis Carriers in Aortic Position: Is This the End of Anticoagulation Demonization?
This study confirms the findings of the PROACT trial on the safety profile of reducing oral anticoagulation in patients with an On-X® prosthetic valve in the aortic position.
What Happens with the Truncal Neoaorta?
A single-center, retrospective study from Boston Children’s Hospital reports 35 years of experience with truncal root dilatation.
Valve-Sparing Aortic Root Replacement with Reimplantation vs. Remodeling: A Meta-analysis
This meta-analysis compares reimplantation and remodeling techniques for valve-sparing aortic root replacement (VSARR) in patients with a dilated aortic root. It includes data from comparative studies on reimplantation and remodeling techniques for VSARR published up to December 31, 2022.
New procedures for a minimally invasive era: transapical beating-heart septal myectomy for hypertrophic obstructive cardiomyopathy.
This study, conducted as a prospective, single-center (Tongji Hospital in Wuhan, China), single-arm trial by a single surgeon, is the first in humans to assess the transapical beating-heart septal myectomy (TA-BSM) procedure.
